207 related articles for article (PubMed ID: 19760611)
1. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
Chen YI; Huang CS
Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
[TBL] [Abstract][Full Text] [Related]
2. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Chen YI; Huang CS
Stat Med; 2014 Feb; 33(5):786-97. PubMed ID: 24105871
[TBL] [Abstract][Full Text] [Related]
3. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
Panhard X; Mentré F
Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
[TBL] [Abstract][Full Text] [Related]
4. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
Liao JJ
Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
[TBL] [Abstract][Full Text] [Related]
5. Use of Bayesian methods for multivariate bioequivalence measures.
Molina de Souza R; Achcar JA; Martinez EZ
J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
[TBL] [Abstract][Full Text] [Related]
6. Tests for individual and population bioequivalence based on generalized p-values.
McNally RJ; Iyer H; Mathew T
Stat Med; 2003 Jan; 22(1):31-53. PubMed ID: 12486750
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: use of replicate design approach.
Idkaidek NM; Al-Ghazawi A; Najib NM
Biopharm Drug Dispos; 2004 Dec; 25(9):367-72. PubMed ID: 15495146
[TBL] [Abstract][Full Text] [Related]
9. A three-step procedure for assessing bioequivalence in the general mixed model framework.
Vuorinen J; Turunen J
Stat Med; 1996 Dec; 15(24):2635-55. PubMed ID: 8981677
[TBL] [Abstract][Full Text] [Related]
10. Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalence.
Dhariwal K; Jackson A
Biopharm Drug Dispos; 2003 Jul; 24(5):219-28. PubMed ID: 12784322
[TBL] [Abstract][Full Text] [Related]
11. Average bioequivalence for two-sequence two-period crossover design with incomplete data.
Lee JY; Kim BC; Park SG
J Biopharm Stat; 2005; 15(5):857-67. PubMed ID: 16078389
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
Chompootaweep S; Poonsrisawat J; Xumseang P
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial.
Alonso Campero R; Bernardo Escudero R; Del Cisne Valle Alvarez D; González de la Parra M; Namur Montalvo S; Burke Fraga V; Silva Hernandez R; De Lago Acosta A
Clin Ther; 2007 Feb; 29(2):326-33. PubMed ID: 17472824
[TBL] [Abstract][Full Text] [Related]
15. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
[TBL] [Abstract][Full Text] [Related]
17. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
[TBL] [Abstract][Full Text] [Related]
18. Examining outlying subjects and outlying records in bioequivalence trials.
Wang W; Chow SC
J Biopharm Stat; 2003 Feb; 13(1):43-56. PubMed ID: 12635902
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
[TBL] [Abstract][Full Text] [Related]
20. Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers.
Mignini F; Streccioni V; Tomassoni D; Traini E; Amenta F
Clin Exp Hypertens; 2007 Nov; 29(8):575-86. PubMed ID: 18058482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
